Ampio Pharmaceuticals(AMPE) - 2018 Q4 - Annual Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10‑K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001‑35182 AMPIO PHARMACEUTICALS, INC. (www.ampiopharma.com) NYSE American: AMPE Delaware 26‑0179592 (State or other jurisdiction of incorporation or organiz ...